← Evidence map

ArticleNeuro-oncology advances

NEO212, temozolomide conjugated to NEO100, exerts superior therapeutic activity over temozolomide in preclinical chemoradiation models of glioblastoma.

Radu O Minea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 39022643